The Medicare Part D program, an optional prescription drug benefit plan, currently covers over two-thirds of Medicare beneficiaries. The changing prescription drug landscape, including rising prices for prescriptions, has challenged the design of the program. This briefing oriented the audience to proposals introduced by Congress and the administration to reform Medicare Part D. Panelists examined trends in Part D spending and discussed the implications of proposed reforms for beneficiaries and the prescription drug market.
Tara O’Neill Hayes, MSPPM
Deputy Director of Health Care Policy, American Action Forum
Tricia Neuman, Sc.D.
Senior Vice President and Director of Program on Medicare Policy, Kaiser Family Foundation
Leigh Purvis, MPA
Director of Health Services Research, AARP Public Policy Institute
Associate Principal, Avalere
Sarah J. Dash, MPH
President and CEO, Alliance for Health Policy (Moderator)
This event was made possible by the Arnold Foundation.